Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis ; volume:17 ; number:1 ; day:15 ; month:1 ; year:2019 ; pages:1-13 ; date:12.2019
BMC medicine ; 17, Heft 1 (15.1.2019), 1-13, 12.2019
- Urheber
-
Bolton, Monica
Hodkinson, Alex
Boda, Shivani
Mould, Alan
Panagioti, Maria
Rhodes, Sarah
Riste, Lisa
Marwijk, Harm van
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-018-1242-0
- URN
-
urn:nbn:de:101:1-2019030423473485540244
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bolton, Monica
- Hodkinson, Alex
- Boda, Shivani
- Mould, Alan
- Panagioti, Maria
- Rhodes, Sarah
- Riste, Lisa
- Marwijk, Harm van
- SpringerLink (Online service)
Ähnliche Objekte (12)
Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
Modeling an IT Support for Handling Serious Adverse Events in Clinical Trials
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
“Serious Adverse Events” Faced by Clinical Trials: Impact of the COVID-19 Pandemic
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
Serious adverse events and compensation in registration trials: a review of data from a Japanese university hospital
Literature review of vaccine-related adverse events reported from HPV vaccination in randomized controlled trials
Adverse Event Reporting in Cancer Clinical Trials: Incorporating Patient-Reported Methods. A Systematic Scoping Review
Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
Modeling an IT Support for Handling Serious Adverse Events in Clinical Trials
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
“Serious Adverse Events” Faced by Clinical Trials: Impact of the COVID-19 Pandemic
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
Serious adverse events and compensation in registration trials: a review of data from a Japanese university hospital
Literature review of vaccine-related adverse events reported from HPV vaccination in randomized controlled trials
Adverse Event Reporting in Cancer Clinical Trials: Incorporating Patient-Reported Methods. A Systematic Scoping Review
Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
Modeling an IT Support for Handling Serious Adverse Events in Clinical Trials
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
“Serious Adverse Events” Faced by Clinical Trials: Impact of the COVID-19 Pandemic
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
Serious adverse events and compensation in registration trials: a review of data from a Japanese university hospital
Literature review of vaccine-related adverse events reported from HPV vaccination in randomized controlled trials
Adverse Event Reporting in Cancer Clinical Trials: Incorporating Patient-Reported Methods. A Systematic Scoping Review
Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials